{"id":"https://openalex.org/W3134496889","doi":"https://doi.org/10.1016/j.leukres.2021.106555","title":"A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival","display_name":"A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival","publication_year":2021,"publication_date":"2021-03-02","ids":{"openalex":"https://openalex.org/W3134496889","doi":"https://doi.org/10.1016/j.leukres.2021.106555","mag":"3134496889","pmid":"https://pubmed.ncbi.nlm.nih.gov/33705966"},"language":"en","primary_location":{"id":"doi:10.1016/j.leukres.2021.106555","doi":"https://doi.org/10.1016/j.leukres.2021.106555","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.leukres.2021.106555","pdf_url":null,"source":{"id":"https://openalex.org/S136942575","display_name":"Leukemia Research","issn_l":"0145-2126","issn":["0145-2126","1873-5835"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia Research","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.leukres.2021.106555","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102705548","display_name":"Jacqueline Suen Garcia","orcid":"https://orcid.org/0000-0003-2118-6302","observed_orcids":["https://orcid.org/0000-0003-2118-6302","https://orcid.org/0000-0002-2599-7308"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jacqueline S. Garcia","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Jacqueline_garcia@dfci.harvard.edu","Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Jacqueline_garcia@dfci.harvard.edu","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032988049","display_name":"Ronan T. Swords","orcid":"https://orcid.org/0000-0003-3319-1870","observed_orcids":["https://orcid.org/0000-0003-3319-1870"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronan T. Swords","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012863731","display_name":"Gail J. Roboz","orcid":"https://orcid.org/0000-0002-0384-3658","observed_orcids":["https://orcid.org/0000-0002-0384-3658"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gail J. Roboz","raw_affiliation_strings":["Weill Medical College of Cornell University and New York-Presbyterian Hospital, NY, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Medical College of Cornell University and New York-Presbyterian Hospital, NY, NY, USA","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114046358","display_name":"Meagan A. Jacoby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meagan A. Jacoby","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031784520","display_name":"Wan\u2010Jen Hong","orcid":"https://orcid.org/0000-0002-0134-4927","observed_orcids":["https://orcid.org/0000-0002-0134-4927"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wan-Jen Hong","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-0134-4927","affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108378639","display_name":"Xiaoqing Yang","orcid":"https://orcid.org/0000-0001-5808-4380","observed_orcids":["https://orcid.org/0000-0001-5808-4380"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoqing Yang","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100733638","display_name":"Ying Zhou","orcid":"https://orcid.org/0000-0002-4145-6376","observed_orcids":["https://orcid.org/0000-0002-4145-6376"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Zhou","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079124367","display_name":"Uwe Platzbecker","orcid":"https://orcid.org/0000-0003-1863-3239","observed_orcids":["https://orcid.org/0000-0003-1863-3239"]},"institutions":[{"id":"https://openalex.org/I4210125843","display_name":"University Hospital Leipzig","ror":"https://ror.org/028hv5492","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210125843"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uwe Platzbecker","raw_affiliation_strings":["Leipzig University Hospital, Leipzig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leipzig University Hospital, Leipzig, Germany","institution_ids":["https://openalex.org/I4210125843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090527595","display_name":"David P. Steensma","orcid":"https://orcid.org/0000-0001-5130-9284","observed_orcids":["https://orcid.org/0000-0001-5130-9284"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Steensma","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062013948","display_name":"Johannes Ernst Alexander Wolff","orcid":"https://orcid.org/0000-0003-0278-1309","observed_orcids":["https://orcid.org/0000-0003-0278-1309"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johannes E. Wolff","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014838075","display_name":"Pierre Fenaux","orcid":"https://orcid.org/0000-0002-0468-3553","observed_orcids":["https://orcid.org/0000-0002-0468-3553"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Fenaux","raw_affiliation_strings":["H\u00f4pital Saint-Louis, Assistance Publique - H\u00f4pitaux de Paris, Universit\u00e9 de Paris, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Saint-Louis, Assistance Publique - H\u00f4pitaux de Paris, Universit\u00e9 de Paris, Paris, France","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5102705548"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":3450,"currency":"USD","value_usd":3450},"apc_paid":{"value":3450,"currency":"USD","value_usd":3450},"fwci":1.1886,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.76138614,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"104","issue":null,"first_page":"106555","last_page":"106555"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/higher-risk-myelodysplastic-syndromes","display_name":"high-risk myelodysplastic syndrome","score":0.9449999928474426},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9599999785423279},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9559999704360962},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.7950000166893005},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8799999952316284},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7910000085830688},{"id":"https://openalex.org/keywords/clinical-trial-endpoints","display_name":"clinical trial endpoints","score":0.6060000061988831},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.9546729326248169},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.721260666847229},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.678605318069458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6640911102294922},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6191121935844421},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6030596494674683},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.5813177227973938},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.5629880428314209},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5151625871658325},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.5046354532241821},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.1098686158657074},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.leukres.2021.106555","doi":"https://doi.org/10.1016/j.leukres.2021.106555","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.leukres.2021.106555","pdf_url":null,"source":{"id":"https://openalex.org/S136942575","display_name":"Leukemia Research","issn_l":"0145-2126","issn":["0145-2126","1873-5835"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia Research","raw_type":"journal-article"},{"id":"pmid:33705966","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33705966","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia research","raw_type":"Journal Article"},{"id":"pmh:oai:digitalcommons.wustl.edu:oa_4-1967","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.wustl.edu/oa_4/977","pdf_url":null,"source":{"id":"https://openalex.org/S4306400764","display_name":"Digital Commons@Becker (Washington University School of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204465549","host_organization_name":"Washington University in St. Louis","host_organization_lineage":["https://openalex.org/I204465549"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"2020-Current year OA Pubs","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1016/j.leukres.2021.106555","doi":"https://doi.org/10.1016/j.leukres.2021.106555","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.leukres.2021.106555","pdf_url":null,"source":{"id":"https://openalex.org/S136942575","display_name":"Leukemia Research","issn_l":"0145-2126","issn":["0145-2126","1873-5835"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W187238933","https://openalex.org/W434887191","https://openalex.org/W1558398160","https://openalex.org/W1605230984","https://openalex.org/W1764888106","https://openalex.org/W1823964213","https://openalex.org/W1978139932","https://openalex.org/W1983306434","https://openalex.org/W1983624670","https://openalex.org/W1985046983","https://openalex.org/W2005969440","https://openalex.org/W2015776863","https://openalex.org/W2052408887","https://openalex.org/W2054439285","https://openalex.org/W2066302281","https://openalex.org/W2080675410","https://openalex.org/W2098454439","https://openalex.org/W2104319503","https://openalex.org/W2106584820","https://openalex.org/W2107328434","https://openalex.org/W2116453057","https://openalex.org/W2118771330","https://openalex.org/W2121710010","https://openalex.org/W2126930838","https://openalex.org/W2129510594","https://openalex.org/W2155949904","https://openalex.org/W2170892587","https://openalex.org/W2171077812","https://openalex.org/W2183584641","https://openalex.org/W2294083716","https://openalex.org/W2326121745","https://openalex.org/W2326726820","https://openalex.org/W2556686067","https://openalex.org/W2576440140","https://openalex.org/W2582511777","https://openalex.org/W2587066646","https://openalex.org/W2613190989","https://openalex.org/W2765262626","https://openalex.org/W2781668746","https://openalex.org/W2886368623","https://openalex.org/W2888468261","https://openalex.org/W2906085839","https://openalex.org/W2911989837","https://openalex.org/W2922405080","https://openalex.org/W3022903699","https://openalex.org/W4214894679","https://openalex.org/W4240874411"],"related_works":["https://openalex.org/W2808502933","https://openalex.org/W4387496269","https://openalex.org/W4286294352","https://openalex.org/W2972524465","https://openalex.org/W2094003121","https://openalex.org/W4308319341","https://openalex.org/W4389991038","https://openalex.org/W1558398160","https://openalex.org/W2160615210","https://openalex.org/W4283326463"],"abstract_inverted_index":{"The":[0],"hypomethylating":[1],"agent":[2],"azacitidine":[3,212],"can":[4],"prolong":[5],"overall":[6],"survival":[7,156,166],"(OS)":[8],"in":[9],"patients":[10,87],"with":[11,55,89,135,153,169],"higher":[12],"risk-myelodysplastic":[13],"syndromes":[14],"(HR-MDS)":[15],"compared":[16],"to":[17,29,37,60,81,131,192],"conventional":[18],"regimens.":[19],"However,":[20],"outcomes":[21,84],"differ":[22],"largely":[23],"between":[24,44],"studies,":[25],"making":[26,57],"it":[27,58],"challenging":[28,59],"determine":[30],"the":[31,193],"contribution":[32],"of":[33,77],"novel":[34],"therapies":[35],"added":[36],"azacitidine.":[38,90],"Further,":[39],"a":[40,69,149,186,190],"discrepancy":[41],"is":[42],"seen":[43],"complete":[45],"(CR)":[46],"or":[47],"partial":[48],"(PR)":[49],"response":[50],"rates":[51,167,172],"and":[52,73,115,148,200],"OS":[53,117,171,195],"improvement":[54],"azacitidine,":[56],"rely":[61],"on":[62],"earlier":[63],"endpoints":[64],"than":[65],"OS.":[66],"We":[67],"conducted":[68],"systematic":[70,75],"literature":[71],"search":[72],"study-level":[74],"review":[76],"237":[78],"clinical":[79,209],"studies":[80],"better":[82],"understand":[83],"for":[85,189,206],"HR-MDS":[86],"treated":[88],"Pooled":[91],"marrow":[92],"CR":[93,103,136],"was":[94,105,119,133],"9%":[95],"(N":[96,108,122,178],"=":[97,109,123,143,160,179],"2654;":[98],"95%":[99,111,125],"CI:":[100,112,126],"6\u201313":[101],"%),":[102,114],"rate":[104,137],"17":[106],"%":[107],"6943;":[110],"15\u201320":[113],"median":[116,154],"(mOS)":[118],"18.6":[120],"months":[121],"2820;":[124],"15.3\u201321.9).":[127],"A":[128],"weak":[129],"correlation":[130,152],"mOS":[132],"detected":[134],"(207":[138],"patient":[139,181,198],"cohorts,":[140],"Pearson\u2019s":[141],"r":[142],"0.315;":[144],"P":[145,159],"<":[146],"0.0005),":[147],"much":[150],"stronger":[151],"progression-free":[155,165],"(mPFS)":[157],"(r=0.88,":[158],"3":[161],"\u00d7":[162],"10\u221214).":[163],"Six-months":[164],"correlated":[168],"1-year":[170],"but":[173],"were":[174],"only":[175],"infrequently":[176],"reported":[177],"41":[180],"cohorts)":[182],"therefore":[183],"not":[184],"allowing":[185],"robust":[187],"recommendation":[188],"surrogate":[191],"established":[194],"endpoint.":[196],"Larger":[197],"numbers":[199],"patient-level":[201],"data":[202],"appear":[203],"necessary,":[204],"especially":[205],"designing":[207],"future":[208],"trials":[210],"using":[211],"combinations.":[213]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-15T00:00:00"}